The New York Times has a new article about a recent study examining the adjunctive use of Risperdal in treating PTSD. Specifically, patients who were already taking a serotonin reuptake inhibitor either were, or were not, given Risperdal as well. Via a variety of metrics they were then assessed after six months to see if the Risperdal made a difference.
Let's begin where the article does, with its headline, "Drugs Found Ineffective for Veterans’ Stress". First of all, the study only examined one drug (granted, it did so in conjunction with a myriad of others, but its findings all relate to one drug), making the Times' use of the plural deeply wrong. In case you want to excuse the writer (Benedict Carey) and just blame the editor for a careless headline, here's the first sentence, which abuses the plural as well, "Drugs widely prescribed to treat severe post-traumatic stress symptoms for veterans are no more effective than placebos and come with serious side effects, including weight gain and fatigue, researchers reported on Tuesday."
Not only does the sentence abuse its subject to over sensationalize the story, the entire second half exaggerates the research findings upon which this article is based. The research author's only comments on the side effects of Risperdal were, "Adverse events associated with risperidone were not serious."